Ahead of the mega vaccination drive which will be done on January 16 the Pune-based vaccine major Serum Institute of India (SII) on Monday received an order from the government for as many as 11 million vaccine doses of Covishield.
According to SII officials, the vaccine would be available at the price of Rs 200 per dose.
The institute had collaborated with the University of Oxford and AstraZeneca to manufacture the Covishield vaccine. Serum Institute of India, the world’s largest vaccine manufacturer, has a license to produce the shot and has already manufactured close to 50 million dose
Earlier the Indian drug regulator approved Covishield and Bharat Biotech’s Covaxin for restricted emergency use in the country.
The vaccination drive against coronavirus in India will kick off on January 16, 2021. The priority will be given to the healthcare workers and the frontline workers, estimated to be around 3 crores, followed by those above 50 years and the under-50 population groups with co-morbidities numbering around 27 crores.